Dear Esteemed Members of
the Korean Society of
Pharmaceutical Science
and Technology (KSPST)
KSPST: The Hub of Innovation Connecting Research and Industry
Dear Esteemed Members of the Korean Society of Pharmaceutical Science and Technology (KSPST),
As we step into the promising year of 2025, I extend my warmest wishes for your health and happiness. Your passion and dedication have been essential to the growth and success of our society, and I truly appreciate your support.
Since its establishment in 1971, KSPST has led the way in advancing pharmaceutical science and boosting the global competitiveness of Korea's pharmaceutical industry. Through flagship events such as the Science Month Symposium, Pharmaceutical Technology Workshop, International Conference of KSPST, and Controlled Release Society (CRS) webinars, we have created a dynamic networking platform that bridges research and industry, opening new horizons in pharmaceutical sciences. Notably, our official journal, Journal of Pharmaceutical Investigation (JPI), has made remarkable progress since its SCIE indexing in 2021, achieving a position among the top 10% of journals in the field. This success reflects the exceptional research capabilities, dedication, and steadfast support of our members.
Amid societal and technological shifts, including new diseases and an aging population, the need for swift and effective strategies to develop innovative medicines has never been greater. Overcoming the critical "Death Valley" in the drug development process remains a key challenge, and the role of KSPST in tackling this issue is more important than ever. To this end, we established the R&D Promotion Committee to create a collaborative R&D platform linking academia, industry, government, and research institutions. By fostering collaborations across these sectors, KSPST is driving efforts to build a thriving ecosystem that turns research into commercial success in the bio-health field.
In 2025, the KSPST leadership team will continue to dedicate itself to connecting research with industry, driving the growth of the pharmaceutical and biotech fields. I sincerely ask for your continued interest and active participation to shape a brighter future.
Together, let us build a community where every member can thrive and be fulfilled.
Thank you.